Park SH - Search Results

1

Luteolin induces intrinsic apoptosis via inhibition of E6/E7 oncogenes and activation of extrinsic and intrinsic signaling pathways in HPV-18-associated cells.

Ham S, Kim KH, Kwon TH, Bak Y, Lee DH, Song YS, Park SH, Park YS, Kim MS, Kang JW, Hong JT, Yoon DY. Ham S, et al. Among authors: park ys, park sh. Oncol Rep. 2014 Jun;31(6):2683-91. doi: 10.3892/or.2014.3157. Epub 2014 Apr 25. Oncol Rep. 2014. PMID: 24789165

2

Luteolin induces cell cycle arrest and apoptosis through extrinsic and intrinsic signaling pathways in MCF-7 breast cancer cells.

Park SH, Ham S, Kwon TH, Kim MS, Lee DH, Kang JW, Oh SR, Yoon DY. Park SH, et al. J Environ Pathol Toxicol Oncol. 2014;33(3):219-31. doi: 10.1615/jenvironpatholtoxicoloncol.2014010923. J Environ Pathol Toxicol Oncol. 2014. PMID: 25272060

3

Interaction network mapping among IL-32 isoforms.

Kang JW, Park YS, Lee DH, Kim MS, Bak Y, Ham SY, Park SH, Kim H, Ahn JH, Hong JT, Yoon DY. Kang JW, et al. Among authors: park ys, park sh. Biochimie. 2014 Jun;101:248-51. doi: 10.1016/j.biochi.2014.01.013. Epub 2014 Jan 25. Biochimie. 2014. PMID: 24472437

4

Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production.

Kang JW, Park YS, Lee DH, Kim MS, Bak Y, Park SH, Ham SY, Yang Y, Hong JT, Yoon DY. Kang JW, et al. Among authors: park ys, park sh. FEBS Lett. 2013 Oct 25:S0014-5793(13)00776-X. doi: 10.1016/j.febslet.2013.10.019. Online ahead of print. FEBS Lett. 2013. PMID: 24512848 Free article.

5

Luteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cells.

Park SH, Kim JH, Lee DH, Kang JW, Song HH, Oh SR, Yoon DY. Park SH, et al. Biochimie. 2013 Nov;95(11):2082-90. doi: 10.1016/j.biochi.2013.07.021. Epub 2013 Aug 8. Biochimie. 2013. PMID: 23933110

6

Differential effects of luteolin and its glycosides on invasion and apoptosis in MDA-MB-231 triple-negative breast cancer cells.

Lee J, Park SH, Lee J, Chun H, Choi MK, Yoon JH, Pham TH, Kim KH, Kwon T, Ryu HW, Oh SR, Yoon DY. Lee J, et al. Among authors: park sh. EXCLI J. 2019 Sep 2;18:750-763. doi: 10.17179/excli2019-1459. eCollection 2019. EXCLI J. 2019. PMID: 31611756 Free PMC article.

7

Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production.

Kang JW, Park YS, Lee DH, Kim MS, Bak Y, Park SH, Ham SY, Yang Y, Hong JT, Yoon DY. Kang JW, et al. Among authors: park ys, park sh. FEBS Lett. 2013 Nov 29;587(23):3776-81. FEBS Lett. 2013. PMID: 24396867

8

NLRP3 negatively regulates Treg differentiation through Kpna2-mediated nuclear translocation.

Park SH, Ham S, Lee A, Möller A, Kim TS. Park SH, et al. J Biol Chem. 2019 Nov 22;294(47):17951-17961. doi: 10.1074/jbc.RA119.010545. Epub 2019 Oct 9. J Biol Chem. 2019. PMID: 31597697 Free PMC article.

9

5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities.

Song JH, Lee JE, Cho KM, Park SH, Kim HJ, Kim YC, Kim TS. Song JH, et al. Among authors: park sh. Mol Carcinog. 2016 May;55(5):611-21. doi: 10.1002/mc.22307. Epub 2015 Mar 18. Mol Carcinog. 2016. PMID: 25788004

10

MMHD [(S,E)-2-methyl-1-(2-methylthiazol-4-yl) hexa-1,5-dien-ol], a novel synthetic compound derived from epothilone, suppresses nuclear factor-kappaB-mediated cytokine expression in lipopolysaccharide-stimulated BV-2 microglia.

Jeon NR, Koppula S, Kim BW, Park SH, Lee HW, Choi DK. Jeon NR, et al. Among authors: park sh. J Pharmacol Sci. 2010;112(2):158-66. doi: 10.1254/jphs.09239fp. Epub 2010 Feb 4. J Pharmacol Sci. 2010. PMID: 20134118 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,221 results

Search Page

Filters